在炎症性肠道疾病中解开营养-微生物群联系
Marilina Florio1, Lucilla Crudele2, Fabio Sallustio3
1Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy.
Molecular aspects of medicine
|February 8, 2025
概括
饮食干预可以通过调节肠道微生物群 (GM) 来显著影响炎症性肠病 (IBD). 地中海饮食有望恢复肠道健康并改善IBD患者的结果,与西方饮食不同.
科学领域:
- 胃肠病学和营养科学 胃肠病学和营养科学
- 微生物组研究 微生物组研究
背景情况:
- 炎症性肠病 (IBD) 涉及慢性胃肠道炎症,肠道屏障功能受损,免疫功能过度活化和肠道失调.
- 肠道微生物群 (GM) 的改变,包括减少有益细菌和增加病原生物,是IBD的特征.
- 饮食和营养被认为是影响IBD病原和管理中的转基因成分和功能的关键因素.
研究的目的:
- 审查宏观营养素,饮食方案和转基因调节在炎症性肠病 (IBD) 患者中的作用.
- 评估不同饮食模式对肠道健康和IBD炎症的影响.
- 讨论IBD管理和改善患者生活质量的营养策略的潜力.
主要方法:
- 文献综述综合了当前关于饮食,肠道微生物群和IBD的证据.
- 分析西式和地中海饮食模式对肠道生理学和免疫反应的影响.
- 检查宏观营养素的作用和各种饮食方案在IBD管理中的有效性.
主要成果:
- 西式饮食通过促进异常免疫反应和损害肠道屏障完整性来加剧IBD.
- 地中海的营养模式显示出有益的效果,促进肠道活化,维护肠道屏障和免疫功能.
- 营养干预可以积极影响转基因成分,可能导致IBD患者的坚持和结果的改善.
结论:
- 饮食模式显著影响肠道微生物群和炎症性肠道疾病 (IBD) 患者的肠道健康.
- 地中海饮食成为IBD的有益方案,支持肠道平衡,并可能改善患者的生活质量.
- 需要进一步的研究来完善IBD营养指南,并推进针对个性化患者护理的精密营养策略.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
304
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
304
01:17Irritable Bowel Syndrome I: Introduction
231
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
231
01:30Inflammatory Bowel Disease II: Crohn's Disease
171
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
171
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
126
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
126
01:50What is Monogastric Digestion?
70.4K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.4K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
99
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
99